S. Ulrich (Zurich, Switzerland), L. Howard (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
This session includes the Best Abstract for Assembly 13 - Pulmonary Vascular Diseases, entitled "Current strategies for managing CTEPH”
Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
A. FAUCHE (BREST, France), E. Presles (SAINT ETIENNE, France), O. Sanchez (PARIS, France), X. Jaïs (PARIS, France), R. Le Mao (BREST, France), P. Robin (BREST, France), G. Pernod (GRENOBLE, France), L. Bertoletti (GRENOBLE, France), P. Jego (RENNES, France), F. Parent (PARIS, France), C. Lemarie (BREST, France), F. Leven (BREST, France), P. Le Roux (BREST, France), P. Salaun (BREST, France), M. Nonent (BREST, France), P. Girard (PARIS, France), K. Lacut (BREST, France), L. Savale (PARIS, France), S. Melac (BREST, France), M. Guégan (BREST, France), P. Mismetti (SAINT ETIENNE, France), S. Laporte (SAINT ETIENNE, France), C. Leroyer (BREST, France), D. Montani (PARIS, France), F. Couturaud (BREST, France), C. Tromeur (BREST, France)
|    |
Characteristics of chronic thromboembolic pulmonary hypertension in Ireland
S. Cullivan (Dublin, Ireland), B. Kevane (Dublin, Ireland), F. Niainle (Dublin, Ireland), B. Mccullagh (Dublin, Ireland), S. Gaine (Dublin, Ireland)
| |
Current strategies for managing CTEPH
M. Delcroix (Leuven, Belgium), J. Pepke-Zaba (Cambridge, United Kingdom), E. Fadel (Paris, France), D. Jenkins (Cambridge, United Kingdom), N. Kim (San Diego, United States of America), M. Madani (San Diego, United States of America), H. Matsubara (Okayama, Japan), G. Simonneau (Paris, France), E. Mayer (Bad-Bauheim, Germany), I. Lang (Vienna, Austria)
| |
Clinically applicable machine learning prediction model for pulmonary hypertension due to left heart disease
K. Swinnen (Leuven, Belgium), K. Verstraete (Leuven, Belgium), N. Das (Leuven, Belgium), M. Topalovic (Leuven, Belgium), R. Quarck (Leuven, Belgium), C. Belge (Leuven, Belgium), W. Janssens (Leuven, Belgium), M. Delcroix (Leuven, Belgium)
| |
Effect of breathing oxygen-enriched air on exercise performance in patients with pulmonary hypertension in heart failure with preserved ejection fraction. Randomized, placebo-controlled, cross-over trial.
J. Müller (Zürich, Switzerland), M. Lichtblau (Zürich, Switzerland), S. Saxer (Zürich, Switzerland), L. Riccardo (Zürich, Switzerland), A. Carta (Zürich, Switzerland), S. Schneider (Zürich, Switzerland), C. Berlier (Zürich, Switzerland), M. Furian (Zürich, Switzerland), K. Bloch (Zürich, Switzerland), E. Schwarz (Zürich, Switzerland), S. Ulrich (Zürich, Switzerland)
| |
Survival effects of pulmonary vasodilators in group 3 pulmonary hypertension
T. Dawes (London, United Kingdom), K. Dimopoulos (London, United Kingdom), C. Mccabe (London, United Kingdom), S. Bax (London, United Kingdom), A. Kempny (London, United Kingdom), P. Molyneaux (London, United Kingdom), P. George (London, United Kingdom), V. Kouranos (London, United Kingdom), F. Chua (London, United Kingdom), E. Renzoni (London, United Kingdom), M. Kokosi (London, United Kingdom), A. Wells (London, United Kingdom), S. Wort (London, United Kingdom), L. Price (London, United Kingdom)
| |
Selection of a gene panel related to pulmonary hypertension associated with respiratory diseases
A. Bosacoma (Barcelona, Spain), D. Aguilar (Barcelona, Spain), A. García (Barcelona, Spain), I. Blanco (Barcelona, Spain), C. Martín-Ontiyuelo (Barcelona, Spain), A. Ramírez (Barcelona, Spain), Y. Roger (Barcelona, Spain), J. Osorio (Barcelona, Spain), O. Tura-Ceide (Barcelona, Spain), V. Peinado (Barcelona, Spain), J. Barberà (Barcelona, Spain)
| |
Incremental experience in optimizing in vitro primary culture of human pulmonary arterial endothelial cells harvested from Swan-Ganz catheters
B. Tielemans (Leuven, Belgium), L. Stoian (Leuven, Belgium), A. Wagenaar (Leuven, Belgium), M. Leys (Leuven, Belgium), C. Belge (Leuven, Belgium), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium)
| |
Late Breaking Abstract - Peripheral T-cells and their cytokine production in Chronic Thromboembolic Pulmonary Hypertension.
D. Van Uden (Rotterdam, Netherlands), T. Koudstaal (Rotterdam, Netherlands), J. Van Hulst (Rotterdam, Netherlands), M. Vink (Rotterdam, Netherlands), M. Van Nimwegen (Rotterdam, Netherlands), P. Heukels (Rotterdam, Netherlands), A. Van Den Bosch (Rotterdam, Netherlands), M. Kool (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), K. Boomars (Rotterdam, Netherlands)
| |
Discussion
| |